- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Ophthalmology
Volume 2011 (2011), Article ID 764183, 6 pages
High-Resolution Optical Coherence Tomography Retinal Imaging: A Case Series Illustrating Potential and Limitations
1Retina Research Group, Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada M5T 2S8
2School of Optometry, University of Waterloo, Waterloo, ON, Canada N2L 3G1
Received 15 February 2011; Accepted 24 June 2011
Academic Editor: Eduardo Buchele Rodrigues
Copyright © 2011 Olena Puzyeyeva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Purpose. To present a series of retinal disease cases that were imaged by spectral domain optical coherence tomography (SD-OCT) in order to illustrate the potential and limitations of this new imaging modality. Methods. The series comprised four selected cases (one case each) of age-related macular degeneration (ARMD), diabetic retinopathy (DR), central retinal artery occlusion (CRAO), and branch retinal vein occlusion (BRVO). Patients were imaged using the Heidelberg Spectralis (Heidelberg Engineering, Germany) in SD-OCT mode. Patients also underwent digital fundus photography and clinical assessment. Results. SD-OCT imaging of a case of age-related macular degeneration revealed a subfoveal choroidal neovascular membrane with detachment of the retinal pigment epithelium (RPE) and neurosensory retina. Using SD-OCT, the cases of DR and BRVO both exhibited macular edema with cystoid spaces visible in the outer retina. Conclusions. The ability of SD-OCT to clearly and objectively elucidate subtle morphological changes within the retinal layers provides information that can be used to formulate diagnoses with greater confidence.
Over the past decade, the development of high-speed, wide-bandwidth tuneable light sources in conjunction with high-speed photodetectors has resulted in major gains in the horizontal and depth resolution of optical coherence tomography (OCT) based instrumentation, thereby dramatically improving visualization capabilities during retinal and optic nerve examination [1, 2]. As a result, OCT has found its place as a widely accepted imaging technique, especially in ophthalmology.
The principle of OCT is based on interferometry [3, 4]. In a typical early generation OCT system, visible light (i.e., to visualise the beam) and broadband, short-coherence length, near-IR light are coupled into one branch of a Michelson interferometer. The light is then split into two paths, one leading to a reference mirror and the second is focused onto the retina. Light is reflected and backscattered from refractive index interfaces within the retina according to the optical properties of each interface. The reflected light from the retina (i.e., the sample arm) and from the reference mirror is recoupled into the interferometer, to ultimately be detected after interference in the spectrometer. Using “time domain” OCT, reflection sites at various depths in the tissue can be sampled by changing the path length of the reference arm. However, this mechanism limits the acquisition speed (approx. 400 A-scans/s), is prone to motion artifacts because of the slow scan speed, and makes real-time imaging impossible. The reference-arm mirror is also scanned at a constant velocity, allowing depth scans to be made pixel by pixel across the retina.
SD-OCT has dramatically improved image resolution. Using SD-OCT, broadband interference is measured with spectrally distinct detectors using Fourier analysis (i.e., light signal frequency is modulated as a function of depth), thereby avoiding path length adjustment of the reference arm. The avoidance of depth scanning results in dramatic gains in imaging speed (i.e., 20,000 to 40,000 A-scans/s) and improved signal-to-noise ratio , with an axial resolution of approximately 7 μm, thereby permitting the acquisition of high-resolution, histological detail of the retina captured from the living human eye over a wide field of view. The much improved scan speed of SD-OCT also permits 3D scanning, with minimal impact of eye movements. The SD-OCT scans can also be referenced to simultaneously acquired 2D en-face images, thereby ensuring the accurate spatial location of each OCT A-scan within the 3D image. An example of SD-OCT imaging of a healthy retina is shown in Figure 1.
In this study, we report on the clinical application of SD-OCT using a series of case reports of patients with clinically defined common and/or classic eye diseases in order to highlight some of the potential, the limitations, and the clinical utility of this technology.
Patients were imaged using the Heidelberg Spectralis HRA + OCT (Heidelberg Engineering, Heidelberg, Germany) in SD-OCT mode, using a scan field of 30 degrees horizontally and 15 degrees vertically and 19 to 25 OCT horizontal sections (one section at least every 240 μm). Patients also underwent pupil dilation, digital fundus photography, and clinical assessment. Digital fundus photography was undertaken using a Canon digital fundus camera (Canon CR-DGi, Canon Inc., Japan) with a resolution of 12.8 mega pixels. Clinical assessment comprised visual acuity, stereo fundus biomicroscopy, and binocular indirect ophthalmoscopy, as appropriate.
2.1. The Heidelberg Spectralis HRA and OCT
The Heidelberg Spectralis HRA and OCT (Heidelberg Engineering, Heidelberg, Germany; Software version-220.127.116.11) can be used in any one of six imaging modes, that is, SD-OCT, fluorescein angiography, indocyanine green angiography, autofluorescence, and red-free and infrared imaging. This paper details use of the instrument in SD-OCT mode only. The Heidelberg Spectralis utilizes a broadband light source centered at 870 nm (i.e., no visible light “beacon”) to simultaneously measure multiple wavelengths, a prerequisite of SD-OCT imaging (Heidelberg Retina Angiograph 2 Operating Instructions). Simultaneous confocal scanning laser ophthalmoscopy is used to generate high-resolution images of the retinal surface, thereby providing precise location information of each A-scan within a cross-sectional SD-OCT image. SD-OCT scanning generates 40,000 A-scans/second with an axial resolution of 3.5 microns/pixel digital (7 microns optical) and a transverse resolution of 14 microns . Alignment software continuously tracks any eye movement during image acquisition and then adjusts the position of the A-scan on the retinal surface to ensure accurate registration of cross-sectional OCT images. Using eye tracking and registration technology, multiple images are obtained from a precise location to then be averaged and filtered to remove random noise from the final image. The same eye tracking/registration technology is used to ensure that the instrument automatically rescans images that are influenced by blink artifacts. Similarly, follow-up images are derived from the same area of retina, thereby eliminating subjective placement of the scan by the operator.
3. Case Reports
This series comprised four selected cases (one case each) of age-related macular degeneration (ARMD), diabetic retinopathy (DR), central retinal artery occlusion (CRAO), and branch retinal vein occlusion (BRVO).
3.1. Case 1: Exudative Age-Related Macular Degeneration (ARMD) (Figure 2)
A 81-year-old female patient had a 20-year history of hypertension and a one-year history of type 2 diabetes. At first presentation, her best corrected visual acuity (VA) in the right (OD) and left (OS) eyes was 20/50 and 20/70, respectively. Intraocular pressures (IOPs) were 18 mmHg OD and 20 mmHg OS. Retinal examination revealed a large choroidal neovascular membrane (CNVM) and a probable serous pigment epithelium detachment (PED) OD and soft macular drusen OS (not shown).
3.2. Case 2: Treated Proliferative Diabetic Retinopathy with Clinically Significant Diabetic Macular Edema (Figure 3)
A 51-year-old male patient presented with a 15 year history of type 2 diabetes, having taken oral medications for the first 11 years and having used insulin for the past 4 years. Past ocular history included laser photocoagulation in both eyes. At the initial visit, the best corrected visual acuity was 20/30 (OD) and 20/70 (OS) with IOPs of 20 mmHg OD and OS.
3.3. Case 3: Central Retinal Artery Occlusion (Figure 4)
A 69-year-old male patient had a medical history of stroke and type 2 diabetes for fifteen years. He presented in the clinic with sudden and absolute vision loss OD. Visual acuity was Counting Fingers at 0.3 meters OD and 20/40 OS.
3.4. Case 4: Branch Retinal Vein Occlusion (Figure 5)
A 78-year-old male patient had a 10 year history of hypertension. His past ocular history included cataract surgery to both eyes. The patient complained of blurry vision OS for the past 4 months. At the initial visit, the visual acuity was Counting Fingers at 0.07 meters OD and 20/200 OS with an intraocular pressure of 24 mmHg and 18 mmHg.
SD-OCT imaging technology was used to acquire images of patients with various retinal diseases in order to evaluate the clinical utility, potential, and limitations of the technique. Both SD-OCT and conventional clinical techniques showed choroidal neovascular membrane and pigment epithelial detachment (case of ARMD); neovascularisation at the disc and elsewhere, fibrosis, epiretinal membrane, and laser scars (case of DR); retinal edema and haemorrhages (case of BRVO). In some circumstances, SD-OCT provided visualization of morphological changes associated with retinal diseases that were either not immediately visible or not at all visible, using conventional clinical techniques. For example, SD-OCT revealed neurosensory retinal detachment and Bruch’s/retinal pigment epithelium wrinkling (case of ARMD); cystoid spaces localised in the outer retina (case of DR); thickening and increased reflectance of inner retina (case of CRAO); localisation of depth of macular edema and of haemorrhages (case of BRVO). Thus, SD-OCT revealed structural retinal changes that are not visible by 2-dimensional limited fundus photography. Conversely, the presence of colour information within the digital fundus photography images may be advantageous, while SD-OCT uses a narrow spectrum of wavelengths and therefore has limited colour information. For example, in the case of the CRAO, conventional digital fundus photography showed the presence of infarction more prominently than the cSLO and SD-OCT imaging.
Previous studies have shown that SD-OCT reveals retinal pathology that was not visible using TD-OCT, such as intra-retinal cysts and subretinal fluid . SD-OCT also adds information to complete the clinical picture providing more detailed resolution of retinal changes, such as full-thickness folds of the RPE and intraretinal edema in case of RPE detachment, BRVO, toxoplasma chorioretinitis, and polypoidal choroidal vasculopathy . A feature of the Heidelberg Spectralis instrument is the ability to undertake multiple mode imaging in addition to SD-OCT, including fluorescein angiography, indocyanine green angiography and autofluorescence, and red-free and infrared imaging. These additional imaging modes also provide further information about retinal pathology that can aid diagnosis and management. A description of these imaging modes is provided elsewhere [9, 10].
The ability of SD-OCT to clearly and objectively elucidate subtle morphological changes within the retinal layers provides information that could potentially be useful in the treatment of retinal diseases. This feature provides SD-OCT with a clear superiority over other clinical techniques that do not possess the same resolution. First, high-resolution cross-sectional images allow better visualization of the vitreoretinal interface, the vitreous, retinal structures, and the choroid. Furthermore, 3D images depict volumetric topographic retinal morphology that can be registered relative to images acquired at a different time point and, therefore, change in retinal morphology can be calculated. Second, while taking a follow-up image of a particular patient, the software is capable of automatically and accurately registering images so that the identical retinal area is used to calculate change. This added functionality eliminates the possibility of human error and makes it easier to analyze the data with greater validity. However, automated segmentation of the internal limiting membrane and Bruch’s membrane sometimes requires manual adjustment prior to analysis in patients with retinal diseases.
Nevertheless, SD-OCT has its limitations. This paper clearly demonstrates that hyperreflective lesions such as exudates and haemorrhages, as well as major retinal vessels, resulted in shadowing of the underlying retinal structures, and thereby details of the underlying morphology are lost. In the case exhibiting choroidal neovascular membrane (i.e., Case 1), and diabetic retinopathy/macular edema where the retinal thickness was over 400 μm, it was hard to discern the underlying pathology and choroid.
SD-OCT imaging technology offers a previously unattainable resolution of retinal morphology. The ability of SD-OCT to clearly and objectively elucidate subtle morphological changes within the retinal layers provides information that can be used to potentially formulate diagnoses earlier and with greater confidence. The current generation of SD-OCT instruments will not replace clinical retinal evaluation but do offer further information that can be valuable from a clinical perspective.
This study illustrates the potential and limitations of SD-OCT imaging technology. It demonstrated the ability of SD-OCT to clearly and objectively elucidate subtle morphological changes within the retinal layers that are not visible using conventional clinical techniques. Such information may be useful for the earlier diagnosis and treatment of retinal diseases.
This paper received funding from the Vision Science Research Program (VSRP), Canadian Institute of Health Research (CIHR), and an anonymous donor. John Flanagan is a consultant for Heidelberg Engineering. This study was presented at the Association for Research in Vision and Ophthalmology Annual Meeting (Fort Lauderdale, USA, 2009).
- W. Drexler, “Cellular and functional optical coherence tomography of the human retina: the cogan lecture,” Investigative Ophthalmology and Visual Science, vol. 48, no. 12, pp. 5340–5351, 2007.
- W. Drexler and J. G. Fujimoto, “State-of-the-art retinal optical coherence tomography,” Progress in Retinal and Eye Research, vol. 27, no. 1, pp. 45–88, 2008.
- Z. Ma, R. K. Wang, F. Zhang, and J. Yao, “High-speed spectral domain optical coherence tomography for imaging of biological tissues,” in Proceedings of the Optics in Health Care and Biomedical Optics: Diagnostics and Treatment II, B. Chance, M. Chen, A. E. T. Chiou, and Q. Luo, Eds., vol. 5630 of Proceedings of SPIE, pp. 286–294, Beijing, China, November 2004.
- M. Wojtkowski, R. Leitgeb, A. Kowalczyk, T. Bajraszewski, and A. F. Fercher, “In vivo human retinal imaging by Fourier domain optical coherence tomography,” Journal of Biomedical Optics, vol. 7, no. 3, pp. 457–463, 2002.
- J. F. De Boer, B. Cense, B. H. Park, M. C. Pierce, G. J. Tearney, and B. E. Bouma, “Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography,” Optics Letters, vol. 28, no. 21, pp. 2067–2069, 2003.
- Heidelberg Enginneering, “Spectralis hardware operating instructions,” Technical Specifications, pp. 22–25, 2007.
- D. M. Luviano, M. S. Benz, R. Y. Kim et al., “Selected clinical comparisons of spectral domain and time domain optical coherence tomography,” Ophthalmic Surgery Lasers & Imaging, vol. 40, no. 3, pp. 325–328, 2009.
- M. Singh and C. K. L. Chee, “Spectral domain optical coherence tomography imaging of retinal diseases in Singapore,” Ophthalmic Surgery Lasers & Imaging, vol. 40, no. 3, pp. 336–341, 2009.
- A. Hassenstein and C. H. Meyer, “Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography—a review,” Clinical & Experimental Ophthalmology, vol. 37, no. 1, pp. 130–143, 2009.
- H. M. Helb, P. Charbel Issa, M. Fleckenstein et al., “Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography,” Acta Ophthalmologica, vol. 88, no. 8, pp. 842–849, 2010.